SCHEMBL18200560

SCHEMBL18200560

c1cc(-c2nc(-c3cc4ccccc4c4ccccc34)nc(-c3cc4ccccc4c4ccccc34)n2)cc(-c2nc3ccccc3c3c2ccc2ccccc23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 3/20 0.37
NPC1 O15118 2/20 0.37
LMNA P02545 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPY1R P25929 1/20 0.37
HTT P42858 1/20 0.37
NPY2R P49146 1/20 0.37
ATM Q13315 1/20 0.37
CYP11B1 P15538 1/20 0.36
RECQL P46063 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ADORA2A P29274 1/20 0.35
HPRT1 P00492 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
CYP1A2 P05177 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200445 0.99 MAPT (0.37) MAPTALDH1A1HPGDNPC1LMNA
SCHEMBL18200446 0.94 ATM (0.40) MAPTALDH1A1HPGDNPC1LMNA
SCHEMBL18200539 0.94 MEN1 (0.40) MAPTALDH1A1HPGDNPC1LMNA
SCHEMBL18200739 0.92 MAPT (0.38) MAPTALDH1A1HPGDNPC1LMNA
SCHEMBL18200510 0.91 MAPT (0.37) MAPTALDH1A1HPGDNPC1LMNA
SCHEMBL18200558 0.90 MAPT (0.39) MAPTALDH1A1HPGDNPC1LMNA
SCHEMBL18201007 0.90 ATM (0.45) MAPTALDH1A1HPGDNPC1LMNA
SCHEMBL18201245 0.90 CYP11B1 (0.42) MAPTALDH1A1HPGDNPC1LMNA
SCHEMBL17034878 0.90 MEN1 (0.46) MAPTALDH1A1HPGDNPC1LMNA
SCHEMBL18201174 0.90 LMNA (0.35) MAPTALDH1A1HPGDNPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MAPT 1937/4885ALDH1A1 85/4885HPGD 421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.